PPT-Prostate Cancer Screening and Early Prostate Cancer Management

Dr MariePier StLaurent MD FRCSC UrologicOncology fellow UBC Research scientist Vancouver Prostate Centre Honorarium Bayer PCSC As a urologist I am biased towards prostate cancer screening. Matthew D. Katz, M.D.. Assistant Professor. Urologic Oncology . Robotic and Laparoscopic Surgery. University of Arkansas for Medical Sciences. Winthrop P. Rockefeller Cancer Center. Anatomy Genitourinary System. Norm D. Smith, M.D.. Associate Professor. Co-Director. Urologic Oncology. University of Chicago. United States Preventive Services Task Force (USPSTF). USPSTF Warns Against Blood Test For Prostate Cancer. Essex Biomedical . Sciences Institute (EBSI) . Elena Klenova, University of Essex. the search for a magic molecule. Most Common Types of Cancers in Men. info.cancerresearchuk.org/.../males/index.htm. . Julian Mander . RPH Urology. The . Laytons. Bob . December . 25, 1925 – May 9, 2002. Jack. July 18, 1950 – August 22, 2011. In the news…. On the streets…. Disclosure. I have a prostate. Why I care…. 1:7 & 1:27. Medical Education. This program will include a discussion of investigational agents not approved by the FDA for use in the United States, and data that were presented in abstract form. These data should be considered preliminary until published in a . Ruth Etzioni. Roman Gulati . Lurdes . inouE. Dhamanpreet. Kaur. Fred Hutchinson cancer research center. TODAY’S PRESENTATION. Trends in prostate cancer incidence and mortality. What are the trends really telling us? A mathematical model. Alon Z. Weizer, MD, MS. Associate Professor of Urology. Associate Chair, Surgical Services, . Department of Urology, University of Michigan. Disclosures. Summus (eConsult Platform): Advisory Board. Outline. Environmental Scan. April 2017. Background. The Canadian Partnership Against Cancer collects information annually on . national, provincial . and territorial . prostate . cancer screening guidelines, strategies, and activities. . The second most common cancer diagnosed in men. The incidence increase with age very rare before age of 40, more in western countries particularly Scandinavian countries (low light exposure), and black men are at greatest risk. When to Image Based on . Choosing . Wisely. ®. . and ACR Appropriateness . Criteria. ®. What Is R-SCAN?. 2. C. ollaborative activity . for referring clinicians and radiologists to improve patient . 279 in Mexico, PC prevalence and the consequent impact of PSA screening cannot be accurately measured. Multiple fundamental prognostic factors for PC (among othershave been considered: 1. PSA determin If you decide not to get screened, you can always change your mind later. If you decide to get screened, it does not mean you have to go to the next step. You should discuss each step with your docto –. To treat . or not to treat. Dr Oliver Klein – Medical Oncologist. Prostate Cancer. |. . Epidemiology- Australia. Most common cancers 2012 . Cancer related deaths 2010 . Australian Institute of Health and Welfare.